Auro Laboratories Profile
Key Indicators
- Authorised Capital ₹ 7.00 Cr
- Paid Up Capital ₹ 6.23 Cr
- Company Age 35 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 47.16 Cr
- Satisfied Charges ₹ 8.37 Cr
- Revenue Growth -5.55%
- Profit Growth -60.38%
- Ebitda -58.86%
- Net Worth 10.28%
- Total Assets 31.19%
About Auro Laboratories
Auro Laboratories Limited (ALL) is a leading Public Limited Indian Non-Government Company incorporated in India on 26 May 1989 and has a history of 35 years and eight months. Its registered office is in Thane, Maharashtra, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 530233.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.00 Cr and a paid-up capital of Rs 6.23 Cr.
The company currently has active open charges totaling ₹47.16 Cr. The company has closed loans amounting to ₹8.37 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Auro Laboratories Limited India is Shaan Jain as CFO. Sharat Deorah, Siddhartha Deorah, Vishal Jhunjhunwala, and Three other members serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
L33125MH1989PLC051910
- Company No.
051910
- Stock Symbol
BSE : 530233
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
26 May 1989
- Date of AGM
28 Jun 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
What products or services does Auro Laboratories Limited offer?
Auro Laboratories Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Antacid Drugs.
Who are the key members and board of directors at Auro Laboratories?
Executive Team (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sharat Deorah | Managing Director | 26-May-1989 | Current |
Shaan Jain | CFO | 13-Jan-2024 | Current |
Board Members (5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vishal Jhunjhunwala | Director | 23-Aug-2023 | Current |
Siddhartha Deorah | Whole-Time Director | 16-Dec-2013 | Current |
Kavita Sharma | Director | 27-Mar-2015 | Current |
Mahendra Daga | Director | 01-Apr-2024 | Current |
Kiran Kulkarni | Whole-Time Director | 24-May-2021 | Current |
Financial Performance of Auro Laboratories.
Auro Laboratories Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 5.55% decrease. The company also saw a substantial fall in profitability, with a 60.38% decrease in profit. The company's net worth Soared by an impressive increase of 10.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Auro Laboratories?
In 2023, Auro Laboratories had a promoter holding of 52.09% and a public holding of 47.91%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹47.16 Cr
₹8.37 Cr
Charges Breakdown by Lending Institutions
- Indian Bank : 47.16 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
29 Feb 2024 | Indian Bank | ₹2.00 M | Open |
20 Dec 2002 | Indian Bank | ₹46.96 Cr | Open |
26 Apr 2012 | Allahabad Bank | ₹1.00 Cr | Satisfied |
30 Jul 2011 | Allahabad Bank | ₹6.00 M | Satisfied |
30 Jul 2011 | Allahabad Bank | ₹6.00 M | Satisfied |
How Many Employees Work at Auro Laboratories?
Unlock and access historical data on people associated with Auro Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Auro Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Auro Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.